Newborn liver gene transfer by an HIV-2-based lentiviral vector

Gene Therapy

Volumn 12, Issue 10, 2005, Pages 803-814

  Salani, B ^a   Damonte, P ^a   Zingone, A ^a   Barbieri, O ^b   Chou, J Y ^c   D'Costa, J ^d   Arya, S K ^d   Eva, A ^a   Varesio, L ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Lentiviral vector; Liver transduction; Newborn

Indexed keywords

ALANINE AMINOTRANSFERASE; GENOMIC DNA; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; PLASMID DNA; THROMBOSPONDIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER; LIVER CELL; MOUSE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SENSITIVITY ANALYSIS; SOUTHERN BLOTTING; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS TYPING;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, SOUTHERN; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; HIV-2; LIVER; LUNG; MICE; MICE, INBRED STRAINS; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TRANSDUCTION, GENETIC;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; VESICULAR STOMATITIS VIRUS;

EID: 19944368783     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302473     Document Type: Article

References (68)

1. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40.
2. Xu L et al. Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B. Blood 2003; 101: 3924-3932.
3. Kohn DB, Parkman R. Gene therapy for newborns. FASEB J 1997; 11: 635-639.
4. Tanswell AK, O'Brodovich HM. The present and future role of gene therapy in the newborn. Curr Opin Pediatr 1997; 9: 141-145.
5. Ponder KP et al. Therapeutic neonatal hepatic gene therapy in mucopolysacchardidosis VII dogs. Proc Nat Acad Sci 2002; 99: 13102-13107.
6. Xu L et al. Transduction of hepatocyte after neonatal delivery of Moloney murine Leukemia virus based retroviral vector results in long-term expression of b-glucuronidase in Mucopolysaccharidosis VII Dogs. Mol Ther 2002; 5/2: 141-153.
7. Zanjani ED, Anderson WF. Prospects for in utero human gene therapy. Science 1999; 285: 2084-2088.
8. Fletcher JC, Richter G. Human fetal gene therapy: moral and ethical questions. Hum Gene Ther 1996; 7: 1605-1614.
9. Senut MC, Gage FH. Prenatal gene therapy: can the technical hurdles be overcome? Mol Med Today 1999; 5: 152-156.
10. Zingone A et al. Correction of glycogen storage disease type 1a in a mouse model by gene therapy. J Biol Chem 2000; 275: 828-832.
11. Sun MS et al. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice. Hum Mol Genet 2002; 11: 2155-2164.
12. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
13. Emerman M. Learning from lentiviruses. Nat Genet 2000; 24: 8-9.
14. Villani GR et al. Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer. Biochem J 2002; 364: 747-753.
15. Kafri T et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17: 314-317.
16. Mochizuki H et al. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 1998; 72: 8873-8883.
17. Chinnasamy D et al. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 2000; 96: 1309-1316.
18. Sutton RE, Reitsma MJ, Uchida N, Brown PO. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol 1999; 73: 3649-3660.
19. Ohashi K, Park F, Kay MA. Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo. Hum Gene Ther 2002; 13: 653-663.
20. Park F et al. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 2000; 24: 49-52.
21. D'Costa J et al. Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation. J Gen Virol 2001; 82: 425-434.
22. D'Costa J et al. HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro. J Med Virol 2003; 71: 173-182.
23. Fletcher III TM et al. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J 1996; 15: 6155-6165.
24. Di Marzio P et al. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol 1995; 69: 7909-7916.
25. Rogel ME, Wu LI, Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol 1995; 69: 882-888.
26. Mahalingam S et al. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J Virol 1997; 71: 6339-6347.
27. Kanki PJ et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343: 943-946.
28. Marlink R et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265: 1587-1590.
29. Zhao J et al. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol 2002; 97: 348-358.
30. Bennett KL et al. Most highly repeated dispersed DNA families in the mouse genome. Mol Cell Biol 1984; 4: 1561-1571.
31. Kalpana GV. Retroviral vectors for liver-directed gene therapy. Semin Liver Dis 1999; 19: 27-37.
32. VandenDriessche T et al. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 2002; 100: 813-822.
33. Follenzi A et al. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther 2002; 13: 243-260.
34. Pan D et al. Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol Ther 2002; 6: 19-29.
35. Nguyen TH et al. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther 2002; 6: 199-209.
36. Nash KL et al. Hepatocyte-specific gene expression from integrated lentiviral vectors. J Gene Med 2004; 6: 974-983.
37. Follenzi A et al. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 2004; 103: 3700-3709.
38. MacKenzie TC et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 2002; 6: 349-358.
39. VandenDriessche T et al. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. Proc Natl Acad Sci USA 1999; 96: 10379-10384.
40. Park F, Kay MA. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther 2001; 4: 164-173.
41. Ouyang J, Alway SE. Transgene expression in hypertrophied and aged skeletal muscle in vivo by lentivirus delivery. J Gene Med 2004; 6: 278-287.
42. Kobinger GP et al. Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells. Hum Gene Ther 2003; 14: 1441-1449.
43. Blomer U et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997; 71: 6641-6649.
44. Zufferey R et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.
45. Bensadoun JC et al. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol 2000; 164: 15-24.
46. Hottinger AF et al. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J Neurosci 2000; 20: 5587-5593.
47. Kafri T, van Praag H, Gage FH, Verma IM. Lentiviral vectors: regulated gene expression. Mol Ther 2000; 1: 516-521.
48. Vogel R et al. A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum Gene Ther 2004; 15: 157-165.
49. Fleury S et al. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo. Circulation 2003; 107: 2375-2382.
50. Peng KW et al. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Therapy 2001; 8: 1456-1463.
51. Gusella GL et al. Lentiviral gene transduction of kidney. Hum Gene Ther 2002; 13: 407-414.
52. Schroers R et al. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther 2000; 1: 171-179.
53. Mordelet E et al. Brain engraftment of autologous macrophages transduced with a lentiviral flap vector: an approach to complement brain dysfunctions. Gene Therapy 2002; 9: 46-52.
54. Woods NB et al. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood 2003; 101: 1284-1289.
55. Lu Y et al. Efficient gene transfer into human monocyte-derived macrophages using defective lentiviral vectors. Cell Mol Biol 2003; 49: 1151-1156.
56. Pfeifer A et al. Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther 2001; 3: 319-322.
57. Park F, Ohashi K, Kay MA. The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. Mol Ther 2003; 8: 314-323.
58. Clapp DW, Dumenco LL, Hatzoglou M, Gerson SL. Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer. Blood 1991; 78: 1132-1139.
59. Touraine JL. Perinatal fetal-cell and gene therapy. Int J Immunopharmacol 2000; 22: 1033-1040.
60. Tarantal AF et al. Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): lung-targeting approaches. Mol Ther 2001; 4: 614-621.
61. Meertens L et al. In utero injection of alpha-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression. Hum Gene Ther 2002; 13: 1809-1820.
62. Seppen J et al. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 2003; 8: 593-599.
63. Chen XG et al. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero. Acta Pharmacol Sin 2004; 25: 789-793.
64. Porada CD, Park P, Almeida-Porada G, Zanjani ED. The sheep model of in utero gene therapy. Fetal Diagn Ther 2004; 19: 23-30.
65. Tsui LV et al. Production of human clotting factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nat Biotechnol 2002; 20: 53-57.
66. Grant SG et al. Localization of the mouse Mcf-2 (Dbl) protooncogene within a conserved linkage group on the mouse × chromosome. Cytogenet Cell Genet 1990; 54: 175-181.
67. Hirsch E et al. Defective dendrite elongation but normal fertility in mice lacking the Rho-like GTPase activator Dbl. Mol Cell Biol 2002; 22: 3140-3148.
68. Pastorino S et al. Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer. Gene Therapy 2001; 8: 431-441.